[Lack of effect of the administration of TRH on growth hormone secretion induced by dexamethasone]. 1991

B Burguera, and M Couce, and M Lage, and M D Viña, and C Diéguez, and F F Casanueva
Departamento de Medicina, Hospital General de Galicia, Facultad de Medicina, Universidad de Santiago.

The usually accepted effect of corticosteroids on growth hormone secretion (GH) is the reduction or blockage of secretion. Our laboratory has previously reported that corticosteroids could have an acute stimulatory effect on this secretion; we have now studied the effect of administering THR on corticosteroids induced GH secretion. Three stimulatory tests were performed to three healthy volunteers on different days. Saline administration on time 0 and time 120 minutes (control test) did not modify GH levels. On the contrary, the administration of 4 mg Dexamethasone i.v. on time 0 induced an increase in GH with a maximum peak of 10 = 3.3 micrograms/L after three hours being these differences statistically significant (p less than 0.05) when referred to the control test from 120 to 240 minutes. The corticosteroid GH stimulus presented a peculiar secretion pattern: During two hours there were no changes in basal values and afterwards the values were maintained in maximum peak values during two hours, with a great net release of GH. The administration of THR (400 micrograms iv) 120 minutes after the administration of Dexamethasone did not notify GH secretion pattern when compared with the group receiving only Dexamethasone. To conclude, the administration of corticosteroids is a new and peculiar stimulus for GH secretion. Lack of THR inhibitory function suggests that the corticosteroid stimulatory function is probably at the hypothalamus level.

UI MeSH Term Description Entries
D008297 Male Males
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone
D013973 Thyrotropin-Releasing Hormone A tripeptide that stimulates the release of THYROTROPIN and PROLACTIN. It is synthesized by the neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, TRH (was called TRF) stimulates the release of TSH and PRL from the ANTERIOR PITUITARY GLAND. Protirelin,Thyroliberin,Abbott-38579,Antepan,Proterelin Tartrate,Proterelin Tartrate Hydrate,Protirelin Tartrate (1:1),Relefact TRH,Stimu-TSH,TRH Ferring,TRH Prem,Thypinone,Thyroliberin TRH Merck,Thyrotropin-Releasing Factor,Thyrotropin-Releasing Hormone Tartrate,Abbott 38579,Abbott38579,Hydrate, Proterelin Tartrate,Prem, TRH,Stimu TSH,StimuTSH,TRH, Relefact,Tartrate Hydrate, Proterelin,Thyrotropin Releasing Factor,Thyrotropin Releasing Hormone,Thyrotropin Releasing Hormone Tartrate

Related Publications

B Burguera, and M Couce, and M Lage, and M D Viña, and C Diéguez, and F F Casanueva
July 2001, Journal of investigative medicine : the official publication of the American Federation for Clinical Research,
B Burguera, and M Couce, and M Lage, and M D Viña, and C Diéguez, and F F Casanueva
January 1996, European journal of endocrinology,
B Burguera, and M Couce, and M Lage, and M D Viña, and C Diéguez, and F F Casanueva
October 1987, The American journal of physiology,
B Burguera, and M Couce, and M Lage, and M D Viña, and C Diéguez, and F F Casanueva
February 1974, Nihon Naibunpi Gakkai zasshi,
B Burguera, and M Couce, and M Lage, and M D Viña, and C Diéguez, and F F Casanueva
January 1987, Developmental pharmacology and therapeutics,
B Burguera, and M Couce, and M Lage, and M D Viña, and C Diéguez, and F F Casanueva
January 1997, Hormone research,
B Burguera, and M Couce, and M Lage, and M D Viña, and C Diéguez, and F F Casanueva
July 1989, Journal of molecular endocrinology,
B Burguera, and M Couce, and M Lage, and M D Viña, and C Diéguez, and F F Casanueva
January 1980, Annales d'endocrinologie,
B Burguera, and M Couce, and M Lage, and M D Viña, and C Diéguez, and F F Casanueva
September 1978, Bollettino della Societa italiana di biologia sperimentale,
B Burguera, and M Couce, and M Lage, and M D Viña, and C Diéguez, and F F Casanueva
July 1981, Life sciences,
Copied contents to your clipboard!